Sulfacetamide: Difference between revisions

(Add AntibioticDose SMW query table for dynamic indications by disease)
 
Line 9: Line 9:
*Acne: apply 10% lotion BID
*Acne: apply 10% lotion BID
*Bacterial skin infection, seborrhea: wash affected areas with wash BID
*Bacterial skin infection, seborrhea: wash affected areas with wash BID
===Indications by Disease===
{{#ask: [[Has DrugName::Sulfacetamide]] [[Has Population::Adult]]
|?Treats disease=Disease
|?Has Dose=Dose
|?Has Context=Context
|format=table
|limit=50
|mainlabel=-
|headers=show
|sort=Treats disease
}}


==Pediatric Dosing==
==Pediatric Dosing==
*>2mo, ophthalmic: same as adult dose
*>2mo, ophthalmic: same as adult dose
*>12yo, topical/skin: same as adult dose
*>12yo, topical/skin: same as adult dose
===Indications by Disease===
{{#ask: [[Has DrugName::Sulfacetamide]] [[Has Population::Pediatric]]
|?Treats disease=Disease
|?Has Dose=Dose
|?Has Context=Context
|format=table
|limit=50
|mainlabel=-
|headers=show
|sort=Treats disease
}}


==Special Populations==
==Special Populations==

Latest revision as of 20:38, 20 March 2026

Administration

  • Type: Antibiotic, anti-acne
  • Dosage Forms:
  • Routes of Administration: topical, ophthalmic
  • Common Trade Names:

Adult Dosing

  • Bacterial eye infection: 1-2 drops in affected eye q2h or 0.5inch of ointment q3-4h
  • Acne: apply 10% lotion BID
  • Bacterial skin infection, seborrhea: wash affected areas with wash BID

Indications by Disease

DiseaseDoseContext
Corneal abrasion10% ophthalmic ointment q6 hoursNo Contact Lens

Pediatric Dosing

  • >2mo, ophthalmic: same as adult dose
  • >12yo, topical/skin: same as adult dose

Indications by Disease

Special Populations

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • SJS/TEN
  • Agranulocytosis, aplastic anemia
  • Hepatic necrosis

Common

  • Application site irritation

Pharmacology

  • Half-life: 7-13h
  • Metabolism:
  • Excretion: Renal

Mechanism of Action

  • Bacteriostatic sulfonamide antibiotic: inhibits utilization of para-aminobenzoic acid and inhibits synthesis of bacterial dihydrofolic acid

Comments

See Also

References